Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00205335 · ClinicalTrials.gov registry record · NA

Free Test Strips and Blood Glucose Control

A NA study of Diabetes, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT00205335: Completed NA study of Diabetes, sponsored by University of Wisconsin, Madison.

NCT00205335 is a NA study of Diabetes that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 22 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00205335, a NA study of Diabetes, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

This study is designed to determine if there is an impact on blood glucose control in patients who receive free test strips. Patients in the study have no insurance or insurance that does not cover the purchase of test strips. A comparison of weight, blood pressure, and Hemoglobin A1C from entry to the final visit will be used to compare patients' management of their diabetes. Recommended values for these parameters will be used as the standard for comparisons. The investigators anticipate that patients receiving free test strips will show an improvement in the listed parameters as well as in satisfaction with their care.

Conditions Studied

Interventions

  • DEVICE Ascencia Breeze Glucose meter
  • DEVICE Breeze Glucose Monitor (Bayer)

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2004-01
Est. Completion 2007-11
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT00205335 record still lists

NCT00205335 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Ascencia Breeze Glucose meter is the first listed.

NCT00205335 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00205335 about?

NCT00205335 is a clinical study titled "Free Test Strips and Blood Glucose Control". This study is designed to determine if there is an impact on blood glucose control in patients who receive free test strips. Patients in the study have no insurance or insurance that does not cover the purchase of test strips. A comparison of weight, blood pressure, and Hemoglobin A1C from entry to ...

What is the current status of trial NCT00205335?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2004-01. Estimated completion is 2007-11.

What conditions does trial NCT00205335 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT00205335?

The interventions under investigation include: Ascencia Breeze Glucose meter (DEVICE), Breeze Glucose Monitor (Bayer) (DEVICE).

Who is sponsoring clinical trial NCT00205335?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00205335 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00205335's enrollment target sits among peer trials

22 303rd of 338 higher than 36 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00205335, the US trial registry maintained by the National Library of Medicine. NCT00205335 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.